Article(id=1326652820419359121, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652739800642340, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.05.013, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1727539200000, receivedDateStr=2024-09-29, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228280405, onlineDateStr=2026-11-09, pubDate=1746806400000, pubDateStr=2025-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228280405, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228280405, creator=13701087609, updateTime=1794228280405, updator=13701087609, issue=Issue{id=1326652739800642340, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='5', pageStart='429', pageEnd='528', issueExtLink='null', onlineDate='null', pubDate='1746806400000', pubDateStr='2025-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228261184, creator='13701087609', updateTime=1794273040769, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840559311893443, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652739800642340, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840559311893444, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652739800642340, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=501, endPage=509, ext={EN=ArticleExt(id=1326652824173261202, articleId=1326652820419359121, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Meta-analysis of the efficacy and safety of tenofovir and entecavir in the treatment of chronic hepatitis B cirrhosis, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective Based on the published literature and the data from completed clinical trials, the meta-analysis method was used to systematically evaluate the efficacy and safety of tenofovir and entecavir in the treatment of patients with chronic hepatitis B (CHB) cirrhosis.
Methods PubMed, Web of Science, Embase, Clinicaltrials.gov, Cochrane library, China Biomedical Literature Service System database, China National Knowledge Infrastructure and Wanfang database were comprehensively searched. The search period was from the establishment date of the database to May 2024. The research data of tenofovir and entecavir in the treatment of patients with CHB cirrhosis were collected. The Cochrane systematic review method was used to screen the literature, evaluate the quality of the included literature, and extract the included characteristic information for meta-analysis. The outcome indicators included the negative conversion rate of hepatitis B virus (HBV)-DNA, the normalization rate of glutamic-pyruvic transaminase (GPT), the cumulative incidence of hepatocellular carcinoma (HCC), the cumulative mortality rate and the changes in estimated glomerular filtration rate (eGFR).
Results A total of 18 articles were included, involving 13 251 patients. The results showed that at 24 and 48 weeks of treatment, compared with entecavir, the negative conversion rate of HBV-DNA in the tenofovir group[odds ratio (OR)=0.84, 95% confidence interval (CI): 0.65—1.08, P=0.17; OR=0.98, 95%CI: 0.28—3.51, P=0.98] and the normalization rate of GPT (OR=1.12, 95%CI: 0.55—2.28, P=0.76; OR=1.35, 95%CI: 0.77—2.36, P=0.29) basically equivalent; Tenofovir can significantly reduce the incidence of cumulative HCC in patients (OR=0.57, 95%CI: 0.42—0.77, P=0.0003), However, there were no significant differences in cumulative mortality (OR=0.89, 95%CI: 0.44—1.83, P=0.76)and the change of eGFR changes (standardized mean difference: -3.02, 95%CI: -18.46—12.42, P=0.70)between the two groups.
Conclusion Tenofovir and entecavir are basically equivalent in the treatment of CHB cirrhosis patients in terms of HBV-DNA negative conversion rate, eGPT normalization rate, cumulative mortality rate and renal function damage, while the former can significantly reduce the incidence of HCC in patients.
, authors=Zhenling ZHU, Ling GU
*, authorsList=Zhenling ZHU, Ling GU, authorCompany=null, correspAuthors=Ling GU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326652824433308051, articleId=1326652820419359121, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=替诺福韦与恩替卡韦在治疗慢性乙型肝炎肝硬化有效性和安全性的meta分析, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的 根据已发表的文献及已完成的临床试验资料,运用meta分析方法系统评价替诺福韦与恩替卡韦治疗慢性乙型肝炎(chronic hepatitis B,CHB)肝硬化患者的疗效和安全性。
方法 全面检索PubMed、Web of Science、Embase、clinicaltrials.gov、Cochrane library、中国生物医学文献服务系统数据库、中国知网及万方等数据库。检索年限从建库日期起至2024年5月,收集替诺福韦与恩替卡韦治疗CHB肝硬化患者的研究资料,采用Cochrane系统评价方法筛选文献,评价纳入文献的质量,并提取纳入特征信息进行meta分析。结局指标包括乙型肝炎病毒(hepatitis B virus,HBV)-DNA转阴率、谷丙转氨酶(glutamic-pyruvic transaminase,GPT)复常率、累积肝细胞癌(hepatocellular carcinoma,HCC)发生率、累积死亡率及肾小球滤过率估算值(estimated glomerular filtration rate,eGFR)变化。
结果 共纳入18篇文献,包括13 251例患者。结果显示,在治疗24、48周时,与恩替卡韦相比,替诺福韦组患者HBV-DNA转阴率[比值比(odds ratio,OR)=0.84,95%置信区间(confidence interval,CI):0.65~1.08,P=0.17;OR=0.98,95%CI:0.28~3.51,P=0.98]和GPT复常率(OR=1.12,95%CI:0.55~2.28,P=0.76;OR=1.35,95%CI:0.77~2.36,P=0.29)基本相当;替诺福韦可显著降低患者累积HCC的发生率(OR=0.57,95%CI:0.42~0.77,P=0.0003),但两组累积死亡率(OR=0.89,95%CI:0.44~1.83,P=0.76)及eGFR变化(标准化均数差:-3.02,95%CI:-18.46~12.42,P=0.70)无显著差异。
结论 替诺福韦与恩替卡韦在治疗CHB肝硬化患者时,HBV-DNA转阴率、GPT复常率、累积死亡率及肾功能损害基本相当,而前者可显著降低患者HCC的发生率。
, authors=朱振玲, 顾玲
*, authorsList=朱振玲, 顾玲, authorCompany=null, correspAuthors=顾玲, authorNote=
, correspAuthorsNote=
顾玲,主任药师,研究方向:医院药学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=OFq0hjBiNP1ZVQI+TUrviw==, magXml=4YFFdLBR7zYtT6Z9Kpy1KA==, pdfUrl=null, pdf=zNLEPLAcQqSj4+ZHheLsqQ==, pdfFileSize=1126671, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=lFayi4i4PpwAZ6svQNH5qw==, mapNumber=null, fund=null)}, authors=[Author(id=1326652824848544152, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652824915653018, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, authorId=1326652824848544152, language=EN, stringName=Zhenling ZHU, firstName=Zhenling, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Taixing People's Hospital, Taixing 225400, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652825062453659, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, authorId=1326652824848544152, language=CN, stringName=朱振玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=泰兴市人民医院药学部,江苏 泰兴 225400, bio={"content":"
朱振玲,主管药师,研究方向:临床药学。
"}, bioImg=null, bioContent=
朱振玲,主管药师,研究方向:临床药学。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652824747880852, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, xref=null, ext=[AuthorCompanyExt(id=1326652824768852373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, companyId=1326652824747880852, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Taixing People's Hospital, Taixing 225400, Jiangsu Province, China), AuthorCompanyExt(id=1326652824781435286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, companyId=1326652824747880852, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=泰兴市人民医院药学部,江苏 泰兴 225400)])]), Author(id=1326652825154728350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652825247003040, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, authorId=1326652825154728350, language=EN, stringName=Ling GU, firstName=Ling, middleName=null, lastName=GU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=Department of Pharmacy, Taixing People's Hospital, Taixing 225400, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652825330889121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, authorId=1326652825154728350, language=CN, stringName=顾玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=泰兴市人民医院药学部,江苏 泰兴 225400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652824747880852, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, xref=null, ext=[AuthorCompanyExt(id=1326652824768852373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, companyId=1326652824747880852, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Taixing People's Hospital, Taixing 225400, Jiangsu Province, China), AuthorCompanyExt(id=1326652824781435286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, companyId=1326652824747880852, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=泰兴市人民医院药学部,江苏 泰兴 225400)])])], keywords=[Keyword(id=1326652825448329634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, language=EN, orderNo=1, keyword=tenofovir), Keyword(id=1326652825683210659, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, language=EN, orderNo=2, keyword=entecavir), Keyword(id=1326652825750319524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, language=EN, orderNo=3, keyword=chronic hepatitis B), Keyword(id=1326652825813234085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, language=EN, orderNo=4, keyword=liver cirrhosis), Keyword(id=1326652825876148646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, language=EN, orderNo=5, keyword=meta-analysis), Keyword(id=1326652827541287335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, language=CN, orderNo=1, keyword=替诺福韦), Keyword(id=1326652827612590504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, language=CN, orderNo=2, keyword=恩替卡韦), Keyword(id=1326652827709059497, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, language=CN, orderNo=3, keyword=慢性乙型肝炎), Keyword(id=1326652827788751274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, language=CN, orderNo=4, keyword=肝硬化), Keyword(id=1326652827860054443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, language=CN, orderNo=5, keyword=meta分析)], refs=[Reference(id=1326652828120101293, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=JADAD AR, MOORE RA, CARROLL D,
et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?[J]. Control Clin Trials, 1996, 17(1): 1-12., articleTitle=null, refAbstract=null), Reference(id=1326652828191404462, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ZUO SR, ZUO XC, WANG CJ,
et al. A meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection[J]. J Clin Pharmacol, 2015, 55(3): 288-297., articleTitle=null, refAbstract=null), Reference(id=1326652828262707631, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=黄惠娟. 探索富马酸丙酚替诺福韦在乙肝肝硬化失代偿治疗中的安全性及有效性[D]. 郑州: 郑州大学, 2023., articleTitle=null, refAbstract=null), Reference(id=1326652828338205104, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=罗健. 恩替卡韦与替诺福韦对慢性乙型肝炎肝硬化患者肝癌发病率的影响研究[D]. 赣州: 赣南医学院, 2022., articleTitle=null, refAbstract=null), Reference(id=1326652828409508273, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=陈欣, 陈立冬, 李庭红. 替诺福韦酯治疗多重耐药的乙型肝炎肝硬化患者疗效初步研究[J]. 实用肝脏病杂志, 2018,21(5): 681-684., articleTitle=null, refAbstract=null), Reference(id=1326652828501782962, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=张笛, 李贞茂, 王治兰, 等. 不同抗病毒药物治疗前后乙肝肝硬化失代偿期患者血清IL-17的观察[J]. 四川医学,2019, 40(10): 990-992., articleTitle=null, refAbstract=null), Reference(id=1326652828602446259, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=刘艳. 核苷类药物在乙型肝炎后肝硬化治疗中的疗效及对上消化道出血症状影响探析[J]. 现代消化及介入诊疗,2018, 23: 103., articleTitle=null, refAbstract=null), Reference(id=1326652828665360820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=王莉琳, 鲁俊锋, 祖红梅, 等. 富马酸丙酚替诺福韦初始治疗失代偿期乙型肝炎肝硬化的早期疗效[J]. 中国肝脏病杂志(电子版), 2021, 13(3): 1-8., articleTitle=null, refAbstract=null), Reference(id=1326652828732469685, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=LIN YH, LAI HL, WANG CH,
et al. Entecavir versus tenofovir disoproxil fumarate on the reduction of incidence of hepatocellular carcinoma in patients with chronic hepatitis B-related liver cirrhosis[J]. Adv Dig Med, 2024, 11(1): 16-23., articleTitle=null, refAbstract=null), Reference(id=1326652828803772854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=HU TH, YUEH-HSIA CHIU S, TSENG PL,
et al. Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan[J]. Aliment Pharmacol Ther, 2020, 52(11-12): 1695-1706., articleTitle=null, refAbstract=null), Reference(id=1326652828866687415, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN CH, CHEN CY, WANG JH,
et al. Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan - a retrospective study[J]. Am J Cancer Res, 2020, 10(11): 3882-3895., articleTitle=null, refAbstract=null), Reference(id=1326652828984127928, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=CHOLONGITAS E, PAPATHEODORIDIS GV, GOULIS J,
et al. The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis[J]. Ann Gastroenterol, 2015, 28(1): 109-117., articleTitle=null, refAbstract=null), Reference(id=1326652829072208313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=KOKLU S, TUNA Y, GULSEN MT,
et al. Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis[J]. Clin Gastroenterol Hepatol, 2013, 11(1): 88-94., articleTitle=null, refAbstract=null), Reference(id=1326652829156094394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=GUI H, HUANG Y, ZHAO G,
et al. External validation of aMAP hepatocellular carcinoma risk score in patients with chronic hepatitis B-related cirrhosis receiving ETV or TDF therapy[J]. Front Med(Lausanne), 2021, 8: 677920., articleTitle=null, refAbstract=null), Reference(id=1326652829239980475, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG YH, SHEN CW, CHEN CY,
et al. Comparative effectiveness of tenofovir versus entecavir in patients with hepatitis B virus-related cirrhosis in Taiwan: a retrospective cohort study[J]. Frontiers in Pharmacol, 2023, 14: 1301120., articleTitle=null, refAbstract=null), Reference(id=1326652829328060860, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE KC, CHENG JS, CHANG ML,
et al. Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study[J].Hepatol Int, 2022, 16(4): 799-806., articleTitle=null, refAbstract=null), Reference(id=1326652829424529853, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=GOYAL SK, DIXIT VK, SHUKLA SK,
et al. Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis[J]. Indian J Gastroenterol, 2015, 34(4): 286-291., articleTitle=null, refAbstract=null), Reference(id=1326652829516804543, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=TSAI MC, CHEN CH, HU TH,
et al. Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs[J]. J Formos Med Assoc, 2017, 116(7): 512-521., articleTitle=null, refAbstract=null), Reference(id=1326652829651022272, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=ALKAN E, AKIN M, TUNA Y. Entecavir and tenofovir treatment in patients with hepatitis B virus-related cirrhosis:a comparison of results of two-year treatment[J]. Klimik Dergisi, 2020, 33(3): 264-269., articleTitle=null, refAbstract=null), Reference(id=1326652829781045697, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=YAO X, HUANG S, ZHOU H,
et al. Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt[J]. World J Gastroenterol, 2021, 27(30): 5088-5099., articleTitle=null, refAbstract=null), Reference(id=1326652829957206466, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=WEN P, CHEN S, WANG J,
et al. Receiver operating characteristics(ROC) analysis for decreased disease risk and elevated treatment response to pegylated-interferon in chronic hepatitis B patients[Z]. Future generat computer systems:Future Generation Computer Systems, 2019, 98: 372-376., articleTitle=null, refAbstract=null), Reference(id=1326652830166921667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=HSU YC, HUANG DQ, NGUYEN MH. Global burden of hepatitis B
virus: current status, missed opportunities and a call for action[J]. Nat Rev Gastroenterol Hepatol, 2023,20(8): 524-537., articleTitle=null, refAbstract=null), Reference(id=1326652830296945092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=CAO G, JING W, LIU J,
et al. Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status[J].Hepatol Int, 2022, 16(6): 1282-1296., articleTitle=null, refAbstract=null)], funds=[Fund(id=1326652828006855084, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, awardId=Q202064, language=CN, fundingSource=江苏省药学会-天晴医院药学基金科研项目(Q202064), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1326652824747880852, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, xref=null, ext=[AuthorCompanyExt(id=1326652824768852373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, companyId=1326652824747880852, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Taixing People's Hospital, Taixing 225400, Jiangsu Province, China), AuthorCompanyExt(id=1326652824781435286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652820419359121, companyId=1326652824747880852, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=泰兴市人民医院药学部,江苏 泰兴 225400)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.05.013, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.05.013, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.05.013, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.05.013, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1746806400000, fullTextJson=null, articleText=null, reference=null)